Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes, and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
A systematic literature review and meta‐analysis of real‐world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes
Glucose Control, Sulfonylureas, and Insulin Treatment in Older Adults With Type 2 Diabetes and Risk of Falls and Fractures: An Observational Study
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis
Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study
<scp>UK</scp>'s Association of British Clinical Diabetologist's Diabetes Technology Network (<scp>ABCD‐DTN</scp>): Best practice guide for hybrid closed‐loop therapy
Beta‐cell death and dysfunction drives hyperglycaemia in organ donors
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)
<scp>C</scp> ontinuous glucose monitoring‐based <scp>time‐in‐range</scp> using insulin glargine 300 units/ <scp>ml</scp> versus insulin degludec 100 units/ <scp>ml</scp> in type 1 diabetes: The <scp>head‐to‐head</scp> randomized controlled <scp>InRange</scp> trial
Hypo‐METRICS: Hypoglycaemia—MEasurement, ThResholds and ImpaCtS—A multi‐country clinical study to define the optimal threshold and duration of sensor‐detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future
Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments
A real‐world study of user characteristics, safety and efficacy of open‐source closed‐loop systems and Medtronic 670G
Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID‐19 global pandemic
Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) project
Differentiating Hypoglycemia Awareness Status from Hypoglycemia Experience in Tools for Measuring Impaired Awareness of Hypoglycemia
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
Structure-functional changes in eNAMPT at high concentrations mediate mouse and human beta cell dysfunction in type 2 diabetes
Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care
Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions
Recurrent diabetic ketoacidosis and a brief history of brittle diabetes research: contemporary and past evidence in diabetic ketoacidosis research including mortality, mental health and prevention
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes
Virus-like infection induces human β cell dedifferentiation
Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology